Revass Utama Medika is Indonesia’s No.1 medical device distributor, providing world-class interventional solutions that empower healthcare institutions across the nation. Founded in 2010, Revass has established itself as a trusted leader in the distribution of high-quality medical devices, serving hospitals and healthcare professionals with cutting-edge products and reliable end-to-end support. Today, Revass plays a vital role in advancing medical technology accessibility, covering over 90% of hospitals in Indonesia equipped with interventional facilities such as catheterization laboratories (Cath Labs), hybrid operating rooms, and advanced cardiac centers. Driven by innovation, integrity, and collaboration, Revass continues to strengthen its position as the most comprehensive medical device distributor in Indonesia, delivering value through quality products, trusted partnerships, and professional service. In November 2023, Revass became part of OrbusNeich Medical Group Holdings Limited, following the acquisition of 84% of Revass’ shares. This strategic partnership strengthens Revass’ role as the bridge between global innovation and local healthcare needs, enabling us to deliver advanced interventional technologies, global clinical training, and world-class service standards. With OrbusNeich’s international presence spanning over 70 countries, Revass now operates with greater capability, scalability, and access to cutting-edge technology, empowering us to better serve healthcare professionals and patients across Indonesia.